APA (7th ed.) Citation

Digomann, D., Heiduk, M., Reiche, C., Glück, J., Kahlert, C., Mirtschink, P., . . . Seifert, A. M. (2023, October). Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer. npj Precision Oncology.

Chicago Style (17th ed.) Citation

Digomann, David, et al. "Serum Immune Checkpoint Profiling Identifies Soluble CD40 as a Biomarker for Pancreatic Cancer." Npj Precision Oncology Oct. 2023.

MLA (9th ed.) Citation

Digomann, David, et al. "Serum Immune Checkpoint Profiling Identifies Soluble CD40 as a Biomarker for Pancreatic Cancer." Npj Precision Oncology, Oct. 2023.